For more than 20 years, the BIO CEO & Investor Conference has provided the biotech industry with networking opportunities with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.
The in person and online 2022 event promises to be one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.